J4D:FRA
Kenvue Inc
€14.50
arrow_downward
-1.96%(-0.29) 1D
බක් 30, 22.00.00 ග්රිමවේ+2 · EUR
search
සියලු සංකේත
1D
5D
1M
6M
YTD
1Y
5Y
උපරි
| සංකේතය | මිල | වෙනස් කිරීම | % වෙනස |
|---|
insights_autoJ4D සඳහා ඉහළම ඇතුළාන්තයන් උත්පාදනය කරමින්...
විවෘත කරන්න
€14.34
ඉහළ
€14.50
පහළ
€14.34
වෙ.පො ප්රාග්ධනය
බි33.46
දළ පරිමාව
96.00
හඬ පරිමාණය
0.00
සති-52 ඉහළ
€22.20
සති-52 පහළ
€11.83
සේවකයින් ගණන
ද22
පුවත් සහ කථා
වෙබය හරහා මූලාශ්ර වෙතින්
පැතිකඩ
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Combantrin, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey.
Johnson & Johnson announced in November 2021 that it would spin off its consumer health division as a separate company. The new company was named Kenvue in September 2022, and its initial public offering took place in May 2023, raising $3.8 billion in the largest U.S. IPO since 2021, with an initial valuation of about $41 billion. Johnson & Johnson initially retained more than 90% ownership before completing a full separation through a share exchange in July 2023. Kenvue was subsequently added to the S&P 500 Dividend Aristocrats index.
CEO Thibaut Mongon initially led Kenvue, which employed about 22,200 people in 2022. Following Mongon’s termination in 2025, Kirk Perry was named interim CEO. Wikipedia
Kenvue Inc ගැන
CEO-
සේවකයින්ද21.9
ආරම්භ කළේ2022 නවම් 23
මූලස්ථානයSummit, න්යූ ජෙර්සි, එක්සත් ජනපදය
අංශයPersonal care products
වෙබ් අඩවියkenvue.com
AI අන්තර්ගතයේ වැරදි ඇතුළත් විය හැක. තව දැන ගන්න